Back to mobile site

AngioDynamics, Inc. (ANGO) Tops Q2 EPS by 7c, Boosts Low End of FY14 Revenue Guidance

January 9, 2014 4:15 PM EST Send to a Friend
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.14, $0.07 better than the analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login